313 related articles for article (PubMed ID: 11677656)
1. ATM as a target for novel radiosensitizers.
Sarkaria JN; Eshleman JS
Semin Radiat Oncol; 2001 Oct; 11(4):316-27. PubMed ID: 11677656
[TBL] [Abstract][Full Text] [Related]
2. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
Lavin MF; Khanna KK
Int J Radiat Biol; 1999 Oct; 75(10):1201-14. PubMed ID: 10549596
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
Sarkaria JN; Busby EC; Tibbetts RS; Roos P; Taya Y; Karnitz LM; Abraham RT
Cancer Res; 1999 Sep; 59(17):4375-82. PubMed ID: 10485486
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update.
Lavin MF
Radiother Oncol; 1998 May; 47(2):113-23. PubMed ID: 9683357
[TBL] [Abstract][Full Text] [Related]
5. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
[TBL] [Abstract][Full Text] [Related]
6. ATM: the product of the gene mutated in ataxia-telangiectasia.
Lavin MF
Int J Biochem Cell Biol; 1999 Jul; 31(7):735-40. PubMed ID: 10467728
[TBL] [Abstract][Full Text] [Related]
7. Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization.
Kuroda S; Urata Y; Fujiwara T
Acta Med Okayama; 2012; 66(2):83-92. PubMed ID: 22525466
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells.
Goodarzi AA; Lees-Miller SP
DNA Repair (Amst); 2004 Jul; 3(7):753-67. PubMed ID: 15177184
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
[TBL] [Abstract][Full Text] [Related]
10. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
Taylor AM; Groom A; Byrd PJ
DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation.
Xue L; Yu D; Furusawa Y; Okayasu R; Tong J; Cao J; Fan S
Mutat Res; 2009 Nov; 670(1-2):15-23. PubMed ID: 19583974
[TBL] [Abstract][Full Text] [Related]
12. Expression of ATM in ataxia telangiectasia fibroblasts rescues defects in DNA double-strand break repair in nuclear extracts.
Li Y; Carty MP; Oakley GG; Seidman MM; Medvedovic M; Dixon K
Environ Mol Mutagen; 2001; 37(2):128-40. PubMed ID: 11246219
[TBL] [Abstract][Full Text] [Related]
13. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
Stewart GS; Last JI; Stankovic T; Haites N; Kidd AM; Byrd PJ; Taylor AM
J Biol Chem; 2001 Aug; 276(32):30133-41. PubMed ID: 11382771
[TBL] [Abstract][Full Text] [Related]
14. Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.
Ziv S; Brenner O; Amariglio N; Smorodinsky NI; Galron R; Carrion DV; Zhang W; Sharma GG; Pandita RK; Agarwal M; Elkon R; Katzin N; Bar-Am I; Pandita TK; Kucherlapati R; Rechavi G; Shiloh Y; Barzilai A
Hum Mol Genet; 2005 Oct; 14(19):2929-43. PubMed ID: 16150740
[TBL] [Abstract][Full Text] [Related]
15. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity.
Mirzayans R; Severin D; Murray D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1498-505. PubMed ID: 17126209
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.
Cariveau MJ; Tang X; Cui XL; Xu B
Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690
[TBL] [Abstract][Full Text] [Related]
17. An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells.
Zhang N; Chen P; Gatei M; Scott S; Khanna KK; Lavin MF
Oncogene; 1998 Aug; 17(7):811-8. PubMed ID: 9779997
[TBL] [Abstract][Full Text] [Related]
18. Enhanced radiation-mediated cell killing of human cervical cancer cells by small interference RNA silencing of ataxia telangiectasia-mutated protein.
Li W; Jian W; Xiaoping X; Yingfeng L; Tao X; Xiaoyan X
Int J Gynecol Cancer; 2006; 16(4):1620-30. PubMed ID: 16884376
[TBL] [Abstract][Full Text] [Related]
19. Ataxia telangiectasia: G2 checkpoint and chromosomal damage in proliferating lymphocytes.
Pincheira J; Bravo M; Navarrete MH; Marcelain K; López-Sáez JF; de la Torre C
Mutagenesis; 2001 Sep; 16(5):419-22. PubMed ID: 11507241
[TBL] [Abstract][Full Text] [Related]
20. Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response.
Tichý A; Vávrová J; Pejchal J; Rezácová M
Acta Medica (Hradec Kralove); 2010; 53(1):13-7. PubMed ID: 20608227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
